To do so, we performed in silico intervention simulations with these nodes based on a progressed cancer condition phenotype (loss of APC and active KRAS, adenocarcinoma phenotype) and compared the attractor landscape to the unperturbed network (Fig. 3C and Appendix Fig. A3, and Appendix Methods A.4). This evidence concerns the gene KRAS and adenocarcinoma.